Antiobesity drugs are amazing people by how fast they melt off pounds. But it's no surprise to Richard DiMarchi.

Viking Therapeutics, Inc. ("Viking") , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the initiation of ...

Can this diabetes-control breakthrough also become the answer to obesity? From Hollywood’s red carpets to affluent Indians, ...

While there is ongoing research to develop better tools like biochemical markers to differentiate fibrosis stage in MASH patients, the only standard currently used in MASH clinical studies involves ...

Learn how blood sugar affects your daily routines, from energy levels to decision-making. Discover practical tips for ...

CHICAGO — GLP-1, or Glucagon-like peptide-1, medications, similar to Ozemppic and Wegovy, are becoming more accessible, and ...

Corxel Pharmaceuticals (CORXEL), a leading biotech company committed to bringing innovative science and medicines to underserved patients with cardiometabolic diseases around the world, today ...

Competition concerns are overblown; Viking's dual GLP-1/GIP agonist has competitive advantages over single-mechanism therapeutics, and concern regarding small-molecule candidates is as yet unfounded.

Glucagon-like peptide 1 receptor agonists ... combine the beneficial effects of two or more hormones into a single molecule — are being explored, with a dual GLP-1R/ gastric inhibitory ...

Structure Therapeutics Inc. has selected a lead oral small-molecule amylin receptor agonist ... that is being evaluated for use either alone or in combination with glucagon-like peptide-1 (GLP-1) ...

Now, a team has found a molecule that could provide caloric restriction in a pill ― at least for flies and worms. There is no evidence yet that taking lithocholic acid would have the same effect ...

Image credit: Shutterstock/ zimmytws. The US Food and Drug Administration (FDA) has issued warning letters to four companies selling unapproved glucagon-like peptide-1 receptor agonist (GLP-1RA) ...